首页期刊导航|世界胃肠病学杂志(英文版)
期刊信息/Journal information
世界胃肠病学杂志(英文版)
世界胃肠病学杂志(英文版)

潘伯荣

周刊

1007-9327

wjg@wjgnet.com

010-85381901-628

100025

北京市朝阳区东四环中路62号楼远洋国际中心D座903室

世界胃肠病学杂志(英文版)/Journal World Journal of GastroenterologyCSCDCSTPCDSCI
查看更多>>主要报道和刊登国内外、特别是我国消化病学者具有创造性的、有较高学术水平的基础和临床研究论文、研究快报等. 对具有中国特色的研究论文, 如食管癌、胃癌、肝癌、大肠癌、病毒性肝炎、幽门螺杆菌、中医中药、中西医结合和基于作者自己研究工作为主的综述性论文, 将优先发表. 读者对象为基础研究或临床研究的消化专业工作者。
正式出版
收录年代

    Analysis of hepcidin expression: In situ hybridization and quantitative polymerase chain reaction from paraffin sections

    Yuhki SakuraokaTokihiko SawadaTakayuki ShirakiKyunghwa Park...
    3727-3731页
    查看更多>>摘要:AIM:TO establish methods for quantitative polymerase chain reaction (PCR) for hepcidin using RNAs isolated from paraffin-embedded sections and in situ hybridization of hepatocellular carcinoma (HCC).METHODS:Total RNA from paraffin-embedded sections was isolated from 68 paraffin-embedded samples of HCC.Samples came from 54 male and 14 female patients with a mean age of 66.8 ± 7.8 years.Quantitative PCR was performed.Immunohistochemistry and in situ hybridization for hepcidin were also performed.RESULTS:Quantitative PCR for hepcidin using RNAs isolated from paraffin-embedded sections of HCC was performed successfully.The expression level of hepcidin mRNA in cancer tissues was significantly higher than that in non-cancer tissues.A method of in situ hybridization for hepcidin was established successfully,and this demonstrated that hepcidin mRNA was expressed in non-cancerous tissue but absent in cancerous tissue.CONCLUSION:We have established novel methods for quantitative PCR for hepcidin using RNAs isolated from paraffin-embedded sections and in situ hybridization of HCC.

    Double layered self-expanding metal stents for malignant esophageal obstruction, especially across the gastroesophageal junction

    Min Dae KimSu Bum ParkDae Hwan KangJae Hyung Lee...
    3732-3737页
    查看更多>>摘要:AIM:TO evaluate the clinical outcomes of double-layered self-expanding metal stents (SEMS) for treatment of malignant esophageal obstruction according to whether SEMS crosses the gastroesophageal junction (GEJ).METHODS:Forty eight patients who underwent the SEMS insertion for malignant esophageal obstruction were enrolled.Patients were classified as GEJ group (SEMS across GEHm 18 patients) and non-GEJ group (SEMS above GEJ,30 patients) according to SEMS position.Double layered (outer uncovered and inner covered stent) esophageal stents were placed.RESULTS:The SEMS insertion and the clinical improvement were achieved in all patients in both groups.Stent malfunction occurred in seven patients in the GEJ group and nine patients in the non-GEJ group.Tumor overgrowth occurred in five and eight patients,respectively,food impaction occurred in one patient in each group,and stent migration occurred in one and no patient,respectively.There were no significant differences between the two groups.Reflux esophagitis occurred more frequently in the GEJ group (eight vs five patients,P =0.036) and was controlled by proton pump inhibitor.Aspiration pneumonia occurred in zero and five patients,respectively,and tracheoesophageal fistula occurred in zero and two patients,respectively.CONCLUSION:Double-layered SEMS are a feasible and effective treatment when placed across the GEJ for malignant esophageal obstruction.Double-layered SEMS provide acceptable complications,especially migration,although reflux esophagitis is more common in the GEJ group.

    Vitamin D deficiency: Correlation to interleukin-17,interleukin-23 and PⅢNP in hepatitis C virus genotype 4

    Mona F SchaalanWaleed A MohamedHesham H Amin
    3738-3744页
    查看更多>>摘要:AIM:To assess vitamin D (Vit D) abnormalities in hepatitis C infected patients and their relationship with interleukin (IL)-17,IL-23 and N-terminal propeptide of type Ⅲ pro-collagen (PⅢNP) as immune response mediators.METHODS:The study was conducted on 50 Egyptian patients (36 male,14 female) with hepatitis C virus (HCV) infection,who visited the Hepatology Outpatient Clinic in the Endemic Disease Hospital at Cairo University.Patients were compared with 25 age-and sexmatched healthy individuals.Inclusion criteria were based on a history of liver disease with HCV genotype 4 (HCV-4) infection (as new patients or under followup).Based on ultrasonography,patients were classified into four subgroups; 14 with bright hepatomegaly; 11 with perihepatic fibrosis; 11 with hepatic cirrhosis; and 14 with cirrhosis and hepatocellular carcinoma (HCC).Total Vit D (i.e.,25-OH-Vit D) and active Vit D [i.e.,1,25-(OH)2-Vit D] assays were carried out using commercial kits.IL-17,IL-23 and PⅢNP levels were assayed using enzyme linked immunosorbent assay kits,while HCV virus was measured by quantitative and qualitative polymerase chain reaction.RESULTS:Levels of Vit D and its active form were significantly lower in advanced liver disease (hepatic cirrhosis and/or carcinoma) patients,compared to those with bright hepatomegaly and perihepatic fibrosis.IL-17,IL-23 and PⅢNP levels were markedly increased in HCV patients and correlated with the progression of hepatic damage.The decrease in Vit D and active Vit D was concomitant with an increase in viral load,as well as levels of IL-17,IL-23 and PⅢNP among all subgroups of HCV-infected patients,compared to normal healthy controls.A significant negative correlation was evident between active Vit D and each of IL-17,IL-23 and PⅢ NP (r =-0.679,-0.801 and-0.920 atP < 0.001,respectively).HCV-infected men and women showed no differences with respect to Vit D levels.The viral load was negatively correlated with Vit D and active Vit D (r =-0.084 and-0.846 at P < 0.001,respectively),and positively correlated with IL-17,IL-23 and PⅢNP (r =0.951,0.922 and 0.94 at P < 0.001,respectively).Whether the deficiency in Vit D was related to HCVinduced chronic liver disease or was a predisposing factor for a higher viral load remains to be elucidated.CONCLUSION:The negative correlations between Vit D and IL-17,IL-23 and PⅢNP highlight their involvement in the immune response in patients with HCV-4-related liver diseases in Egypt.

    PI3K expression and PIK3CA mutations are related to colorectal cancer metastases

    Yu-Fen ZhuBao-Hua YuDa-Li LiHong-Lin Ke...
    3745-3751页
    查看更多>>摘要:AIM:To assess the significance of phosphatidylinositol 3-kinase (PI3K) in colorectal cancer (CRC) and toxicity of LY294002 in CRC cells with different metastatic abilities.METHODS:Sixty formalin-fixed and paraffin-embedded CRC tumor specimens were investigated.Adjacent normal colonic mucosa specimens from 10 of these cases were selected as controls.PI3K protein was detected by immunohistochemistry and PIK3CA mutations were investigated by gene sequencing analysis.A flowcytometry-based apoptosis detection kit was used to determine PI3K inhibitor-induced apoptosis in CRC cell lines SW480 and SW620.Expression of phosphorylated protein kinase B in CRC cell lines was detected by Western blotting.RESULTS:There was a significant difference in the proportion of primary lesions (30%,18/60) vs metastatic lesions (46.7%,28/60) that were positive for PI3K (P <0.05).Mutations were detected in exon 9 (13.3%) and exon 20 (8.3%).Out of 60 cases,seven mutations were identified:two hotspot mutations,C.1633G>A resulting in E545A,and C.3140A>G resulting in H1047R; two novel missense mutations C.1624G>A and C.3079G>A;and three synonymous mutations (C.1641G>A,C.1581C>T and C.3027T>A).Exposure of SW480 cells to PI3K inhibitor for 48 h resulted in a significant increase of apoptotic cells in a dose-dependent manner [3.2% apoptotic cells in 0 μmol/L,4.3% in 5 μmol/L,6.3% in 10 μ.mol/L (P < 0.05),and 6.7% in 20 μmol/L (P < 0.05)].Moreover,PI3K inhibitor induced a similar significant increase of apoptotic cells in the SW620 cell line for 48 h [3.3% apoptotic cells in 0 μmol/L,13.3%in 5 μmol/L (P < 0.01),19.2% in 10 μmol/L (P < 0.01),and 21.3% in 20 μmol/L (P < 0.01)J.CONCLUSION:High PI3K expression is associated with CRC metastasis.PI3K inhibitor induced apoptosis in CRC cells and displayed strong cytotoxicity for highly metastatic cells.PI3K inhibition may be an effective treatment for CRC.

    Evaluation of a novel hybrid bioartificial liver based on a multi-layer fiat-plate bioreactor

    Xiao-Lei ShiYue ZhangXue-Hui ChuBing Han...
    3752-3760页
    查看更多>>摘要:AIM:TO evaluate the efficacy and safety of a hybrid bioartificial liver (HBAL) system in the treatment of acute liver failure.METHODS:Canine models with acute liver failure were introduced with intravenous administration of D-galactosamine.The animals were divided into:the HBAL treatment group (n =8),in which the canines received a 3-h treatment of HBAL; the bioartificial liver (BAL) treatment group (n =8),in which the canines received a 3-h treatment of BAL; the non-bioartificial liver (NBAL) treatment group (n =8),in which the canines received a 3-h treatment of NBAL; the control group (n =8),in which the canines received no additional treatment.Biochemical parameters and survival time were determined.Levels of xenoantibodies,RNA of porcine endogenous retrovirus (PERV) and reverse transcriptase (RT) activity in the plasma were detected.RESULTS:Biochemical parameters were significantly decreased in all treatment groups.The TBIL level in the HBAL group was lower than that in other groups (2.19 ± 0.55 μmol/L vs 24.2 ± 6.45 μmol/L,12.47 ± 3.62 μmol/L,3.77 ± 1.83 μmol/L,P < 0.05).The prothrombin time (PT) in the BAL and HBAL groups was significantly shorter than the NBAL and control groups (18.47 ± 4.41 s,15.5 ± 1.56 s vs 28.67 ± 5.71 s,21.71 ± 3.4 s,P < 0.05),and the PT in the HBAL group was shortest of all the groups.The albumin in the BAL and HBAL groups significantly increased and a significantly higher level was observed in the HBAL group compared with the BAL group (27.7 ± 1.7 g/L vs 25.24 ± 1.93 g/L).In the HBAL group,the ammonia levels significantly decreased from 54.37 ± 6.86 to 37.75 ± 6.09 after treatment (P < 0.05); there were significant difference in ammonia levels between other the groups (P < 0.05).The levels of antibodies were similar before and after treatment.The PERV RNA and the RT activity in the canine plasma were all negative.CONCLUSION:The HBAL showed great efficiency and safety in the treatment of acute liver failure.

    Computed tomography virtual endoscopy with angiographic imaging for the treatment of type Ⅳ-A choledochal cyst

    Akihiko TsuchidaYuichi NagakawaKazuhiko KasuyaBunso Kyo...
    3761-3764页
    查看更多>>摘要:Type Ⅳ-A choledochal cysts (CCs) are a congenital biliary anomaly which involve dilatation of the extrahepatic and intrahepatic bile ducts.We present the case of a 30-year-old woman with type Ⅳ-A CC,on whom threedimensional computed tomography (3D CT) and virtual endoscopy were performed.3D CT revealed partial dilatation in the posterior branch of the intrahepatic bile duct and a relative stricture between it and the extrahepatic bile duct.Virtual endoscopy showed that this stricture was membrane-like and separated from the surrounding blood vessels.Based on these image findings,complete cyst resection,bile duct plasty for the stricture,and hepaticojejunostomy were safely performed.To the best of our knowledge,there are no reports of imaging by virtual endoscopy of the biliarytract which show the surrounding blood vessels running along the bile duct.

    Direct cholangioscopy combined with double-balloon enteroscope-assisted endoscopic retrograde cholangiopancreatography

    Tatsuya KoshitaniShogo MatsudaKoji TakaiTakayuki Motoyoshi...
    3765-3769页
    查看更多>>摘要:Double-balloon enteroscope (DBE)-assisted endoscopic retrograde cholangiopancreatography (ERCP) is an effective endoscopic approach for pancreatobiliary disorders in patients with altered gastrointestinal anatomy.Endoscopic interventions via DBE in these postoperative settings remain difficult because of the lack of an elevator and the use of extra-long ERCP accessories.Here,we report the usefulness of direct cholangioscopy with an ultra-slim gastroscope during DBE-assisted ERCP.Three patients with choledocholithiasis in postoperative settings (two patients after Billroth Ⅱ gastrojejunostomy and one patient after Roux-en-Y gastrojejunostomy)were treated.DBE was used to gain access to the papilla under carbon dioxide insufflation,and endoscopic sphincterotomy was performed with a conventional sphincterotome.For direct cholangioscopy,the enteroscope was exchanged for an ultra-slim gastroscope through an incision in the overtube,which was inserted directly into the bile duct.Direct cholangioscopy was used to extract retained bile duct stones in two cases and to confirm the complete clearance of stones in one case.Bile duct stones were eliminated with a 5-Fr basket catheter under direct visual control.No adverse events were noted in any of the three cases.Direct cholangioscopy with an ultra-slim gastroscope facilitates subsequent treatment within the bile duct.This procedure represents another potential option during DBE-assisted ERCP.

    Multiple esophageal variceal ruptures with massive ascites due to myelofibrosis-induced portal hypertension

    Koichi TokaiHiroyuki MiyataniYukio YoshidaShigeki Yamada...
    3770-3774页
    查看更多>>摘要:A 75-year old man had been diagnosed at 42 years of age as having polycythemia vera and had been monitored at another hospital.Progression of anemia had been recognized at about age 70,and the patient was thus referred to our center in 2008 where secondary myelofibrosis was diagnosed based on bone marrow biopsy findings.Hematemesis due to rupture of esophageal varices occurred in January and February of 2011.The bleeding was stopped by endoscopic variceal ligation.Furthermore,in March of the same year,hematemesis recurred and the patient was transported to our center.He was in irreversible hemorrhagic shock and died.The autopsy showed severe bone marrow fibrosis with mainly argyrophilic fibers,an observation consistent with myelofibrosis.The liver weighed 1856 g the spleen 1572 g,indicating marked hepatosplenomegaly.The liver and spleen both showed extramedullary hemopoiesis.Myelofibrosis is often complicated by portal hypertension and is occasionally associated with gastrointestinal hemorrhage due to esophageal varices.A patient diagnosed as having myelofibrosis needs to be screened for esophageal/gastric varices.Myelofibrosis has a poor prognosis.Therefore,it is necessary to carefully decide the therapeutic strategy in consideration of the patient's concomitant conditions,treatment invasiveness and quality of life.

    Information

    后插1-后插8页